Cardio Diagnostics Holdings, Inc. Revenue
Cardio Diagnostics Holdings, Inc. (CDIO) reported Revenue of $5.36 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. revenues for the quarter ending 2026-06-30 was $5.36K, a 28.29% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. revenues for the quarter ending 2026-03-31 was $2.68K, a 185.11% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. revenues for the quarter ending 2025-12-31 was $3.56K, a 21.21% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. revenues for the quarter ending 2025-09-30 was $2.85K, a 56.61% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. revenues for fiscal 2025 was $14.82K, a 57.51% decline from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. revenues for fiscal 2024 was $34.89K, a 104.45% increase from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. revenues for fiscal 2023 was $17.07K, a 1696.32% increase from fiscal 2022.
- Cardio Diagnostics Holdings, Inc. revenues for fiscal 2022 was $950.00, a 5.44% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.36K 10-Q · filed 2026-08-07 | $8.04K 10-Q · filed 2026-08-07 | $11.60K derived: sum of 3 quarters · filed 2026-08-07 | $14.45K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $2.68K 10-Q · filed 2026-05-15 | $6.24K derived: sum of 2 quarters · filed 2026-05-15 | $9.09K derived: sum of 3 quarters · filed 2026-05-15 | $16.57K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $6.41K derived: sum of 2 quarters · filed 2026-03-13 | $13.88K derived: sum of 3 quarters · filed 2026-08-07 | $14.82K 10-K · filed 2026-03-13 |
| 2025-09-30 | $2.85K 10-Q · filed 2025-11-12 | $10.33K derived: sum of 2 quarters · filed 2026-08-07 | $11.27K 10-Q · filed 2025-11-12 | $15.78K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $7.47K 10-Q · filed 2026-08-07 | $8.41K 10-Q · filed 2026-08-07 | $12.93K derived: sum of 3 quarters · filed 2026-08-07 | $19.51K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $940.00 10-Q · filed 2026-05-15 | $5.45K derived: sum of 2 quarters · filed 2026-05-15 | $12.03K derived: sum of 3 quarters · filed 2026-05-15 | $19.90K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $4.51K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $11.09K derived: sum of 2 quarters · filed 2026-03-13 | $18.96K derived: sum of 3 quarters · filed 2026-03-13 | $34.89K 10-K · filed 2026-03-13 |
| 2024-09-30 | $6.58K 10-Q · filed 2025-11-12 | $14.45K derived: sum of 2 quarters · filed 2025-11-12 | $30.38K 10-Q · filed 2025-11-12 | $35.69K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $7.87K 10-Q · filed 2025-08-14 | $23.80K 10-Q · filed 2025-08-14 | $29.11K derived: sum of 3 quarters · filed 2025-08-14 | $39.14K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $15.93K 10-Q · filed 2025-05-15 | $21.24K derived: sum of 2 quarters · filed 2025-05-15 | $31.27K derived: sum of 3 quarters · filed 2025-05-15 | $32.99K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $5.31K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $15.34K derived: sum of 2 quarters · filed 2025-03-20 | $17.07K derived: sum of 3 quarters · filed 2025-03-20 | $17.07K 10-K · filed 2025-03-20 |
| 2023-09-30 | $10.03K 10-Q · filed 2024-11-13 | $11.76K derived: sum of 2 quarters · filed 2024-11-13 | $11.76K 10-Q · filed 2024-11-13 | $12.71K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $1.73K 10-Q · filed 2024-08-12 | $1.73K 10-Q · filed 2024-08-12 | $2.67K derived: sum of 3 quarters · filed 2024-08-12 | $2.67K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $950.00 derived: sum of 2 quarters · filed 2024-04-01 | $950.00 derived: sum of 3 quarters · filed 2024-04-01 | $950.00 derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-12-31 | $950.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $950.00 derived: sum of 2 quarters · filed 2024-04-01 | $950.00 derived: sum of 3 quarters · filed 2024-04-01 | $950.00 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $901.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |